| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00001756-199904060-00026 |
| P698 | PubMed publication ID | 10321481 |
| P2093 | author name string | Ma D | |
| Kozikowski AP | |||
| Etcheberrigaray R | |||
| Qiao L | |||
| Ibarreta D | |||
| Duchén M | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1035-1040 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | NeuroReport | Q15710007 |
| P1476 | title | Benzolactam (BL) enhances sAPP secretion in fibroblasts and in PC12 cells | |
| P478 | volume | 10 |
| Q57371926 | A Novel γ-Secretase Assay Based on Detection of the Putative C-terminal Fragment-γ of Amyloid β Protein Precursor |
| Q36147173 | Bryostatin-1 vs. TPPB: dose-dependent APP processing and PKC-α, -δ, and -ε isoform activation in SH-SY5Y neuronal cells |
| Q37572741 | Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. |
| Q34019137 | Ionic and signal transduction alterations in Alzheimer's disease: relevance of studies on peripheral cells |
| Q38784086 | Protein Kinase C Activation as a Potential Therapeutic Strategy in Alzheimer's Disease: Is there a Role for Embryonic Lethal Abnormal Vision-like Proteins? |
| Q34673148 | Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress |
| Q34549472 | Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice |
Search more.